The Danish Medicines Verification Organisation (DMVO) was founded on November 21, 2016. It is a limited liability partnership set up to establish, administer and operate a national data storage system in accordance with the requirements of EU legislation.
DMVO has thus been set up to implement an EU Directive in Denmark for an IT system intended to identify falsified medicines. All packs of prescription medicine must have a 2D barcode. This is then checked into the manufacturer's (or parallel importer's) listing on a big European database before being marketed in Europe. When a pack is being dispensed to patients at Danish pharmacies or hospitals, it has to be checked out of the system again.
>>Ensuring even better protection for patients against falsified prescription medicines. <<
DMVO is headed up by a board consisting of six members appointed by
- Danish Association of the Pharmaceutical Industry (Lif)
- Danish Generic Medicines Industry Association (IGL)
- Danish Association of Parallel Importers (PFL) and The Association of Parallel Importers of Pharmaceuticals – jointly one member
- Danish Pharmaceutical Association
The board is required to ensure that the company operates in accordance with the EU Directive, relevant national and international legislation and the company's articles of association. According to the articles of association, the board is required in addition to its duties associated with the company's operations, strategies and objectives, also to delegate day-to-day management to an Executive Director/Head of Secretariat and the board has accordingly decided to appoint a small secretariat with four fulltime staff. DMVO’s secretariat will head up the project and the subsequent operations, undertake the involvement of the regulatory authorities and stakeholders, deal with financial issues, etc.
In the period of April to December 2018, DMVO completed a pilot whereafter the end-users were connected to the system during the ramp-up phase. The pilot phase consisted of a limited number of manufacturers and parallel importers who uploaded their serialised medicines to the European Medicines Verification system via the hub.
The pilot phase resulted in valuable experiences which were put to use in the ramp-up phase and eventually in operation starting the 9. February 2019.
Experiences from the pilot phase can be found here.
DMVO is located at the premises of Lif Group's at Lersø Park Allé 101 in Copenhagen.
See information from The Danish Medicines Verification Organisation ApS to Marketing Authorization Holders (MAHs) in connection with the EU General Data Protection Regulation.
See information from The Danish Medicines Verification Organisation ApS to stakeholders in connection with the EU General Data Protection Regulation.
See information from The Danish Medicines Verification Organisation ApS to suppliers in connection with the EU General Data Protection Regulation.